Ted Karkus - Mar 17, 2024 Form 4/A Insider Report for ProPhase Labs, Inc. (PRPH)

Role
CEO & CHAIRMAN, Director, 10%+ Owner
Signature
/s/ Ted Karkus
Stock symbol
PRPH
Transactions as of
Mar 17, 2024
Transactions value $
$0
Form type
4/A
Date filed
3/21/2024, 04:30 PM
Date Of Original Report
Mar 19, 2024
Previous filing
Apr 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH Option (right to buy) Award $0 +400K $0.00 400K Mar 17, 2024 Common Stock 400K $6.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date.
F2 This amended report on Form 4 is being filed to correct the information in Table II, Box 5 as the share amount was inadvertently reported under the wrong subheading in the original Form 4 filed on March 19, 2024.